Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update

MitoAction Expert Series

Aug 18 2022 | 01:02:07

00:00 / 01:02:07

Show Notes

There was much discussion about current research in FAODs at our recent International Metabolic conference last month. Reneo Pharmaceuticals recently released positive results from the REN001 Phase1b LC-FAOD Study.

Other Episodes

Episode 0

May 20, 2021 • 00:59:18

Clinical Trials: Why you should care and why you should participate. How do we know what we know?

Join MitoAction and Dr. Jerry Vockley from University of Pittsburgh Children’s Hospital on Friday, May 14, 2021 for our monthly expert series presentation! About...

Episode 0

June 08, 2020 • 01:02:14

DTC Testing - Power & Pitfalls - Dr. Fran Kendall - 4/5/19

Join MitoAction and Dr. Frank Kendall to discuss Direct to Consumer genetic testing (DTC testing) in detail. Some talking points will include: Strengths and...

Episode

May 19, 2022 • 01:14:29

PDCD (Pyruvate Dehydrogenase Complex Deficiency)

What is the mitochondrial disorder PDCD? PDCD is an abbreviation for pyruvate dehydrogenase complex deficiency, a genetic mitochondrial disorder in children which is frequently...